Pharma & Biotech

As Moderna navigates its challenging transition beyond pandemic-era vaccine dominance, the biotechnology firm has secured overwhelming shareholder approval for a...

Kezar Life Sciences finds itself navigating a severe operational crisis, marked by significant regulatory setbacks and a dramatic corporate restructuring....

Biopharmaceutical firm Ocugen finds itself navigating turbulent financial waters as its promising gene therapy pipeline advances through clinical trials. The...

The biotechnology firm Amicus Therapeutics has achieved a significant financial breakthrough, reporting its first GAAP profit in years during the...

The biotechnology sector has found renewed optimism as Harmony Biosciences Holdings demonstrates remarkable momentum. Recent developments have positioned the company...

BioXcel Therapeutics finds itself navigating the most severe financial challenge in its corporate history. The biotechnology firm not only reported...

Iovance Biotherapeutics shares have been on a dramatic rollercoaster ride following the company's latest financial results. The biotech stock initially...

Intellia Therapeutics shares are experiencing a dramatic downturn after a patient death in a pivotal clinical study triggered multiple analyst...

The acquisition drama surrounding German biopharmaceutical firm CureVac approaches its climax as investors prepare for a landmark shareholder vote. With...

Danish pharmaceutical giant Novo Nordisk finds itself navigating turbulent waters following a series of damaging developments. Investors are growing increasingly...